All results
48 results for natural history study development type 1 diabetes
-
Clinical Trials
This is a multicenter, Phase Ib, open-label, siplizumab dose-finding study in individuals aged 8-45 years with a Type 1 diabetes mellitus (T1DM) diagnosis.…
-
News, Stories & Blog
University of Florida researchers have identified cells targeted by a male hormone and found that an excess of that hormone at a specific time can cause…
-
News, Stories & Blog
University of Florida adult stem cell experts have restored normal blood sugar levels in diabetic mice for three months by chemically coaxing bone marrow cells…
-
Clinical Trials
This is a natural history study prospectively investigating neuroimaging markers of disease progression in children and adults with Friedreich ataxia (FA).…
-
News, Stories & Blog
Last week, we announced the creation of the UF Diabetes Institute. Given the many fundamental contributions of our faculty to this field over the years, the UF…
-
News, Stories & Blog
The fiscal year for the National Institutes of Health ended on Sept. 30, and I have good news to report: NIH funding at UF Health, the university’s academic…
-
News, Stories & Blog
Here are some things that don't shut down when the government closes: Heart disease. Cancer. Diabetes. Alzheimer's. Schizophrenia. The list goes on.…
-
Clinical Trials
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil,…
-
News, Stories & Blog
Part 2 of our “2018 Year in Review” focuses on the research institutes and centers that are part of the UF Health family: Cancer Center Clinical and…
-
News, Stories & Blog
Part 2 of our “Year in Review” focuses on the hospitals, research institutes and centers that are part of the UF Health family: UF Health Cancer Center UF…